Drug substitution in transplantation: A National Kidney Foundation white paper-Reference-Cited by-同舟云学术

Drug substitution in transplantation: A National Kidney Foundation white paper

Published:1999-02 Issue:2 Volume:33 Page:389-397
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Sabatini Sandra,Ferguson Ronald M.,Helderman J.Harold,Hull Alan R.,Kirkpatrick Beverly S.,Barr William H.

Publisher

Elsevier BV

Subject

Nephrology

Reference32 articles.

1. Guidance for industry: In vivo bioequivalence studies based on population and individual bioequivalence approaches;Individual Bioequivalence Working Group of the Biopharmaceutics Coordinating Committee,1997

2. Types of bioequivalence and related statistical considerations;Hauck;Int J Clin Pharmacol Ther Toxicol,1992

3. Bioequivalence assessment of generic drugs: An American point of view;Patnaik;Eur J Drug Metab Pharmacokinet,1996

4. Bioequivalence and narrow therapeutic index drugs;Benet;Pharmacotherapy,1995

5. What are narrow therapeutic index drugs?;Levy;Clin Pharmacol Ther,1998

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective;Frontiers in Pharmacology;2024-04-18

2. Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs;British Journal of Clinical Pharmacology;2023-02-02

3. Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients;Expert Opinion on Drug Metabolism & Toxicology;2021-06-29

4. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study;Current Medical Research and Opinion;2020-07-22

5. Immunology in Tumor and Transplant;Urologic Principles and Practice;2020